TrueMed

Specialty Retail · Austin, TX · Founded 2022 · Privately Held (backing)

Developer of a healthcare platform designed to enable consumers to use pre-tax HSA/FSA funds for proactive health and wellness purchases. TrueMed is based in Austin, TX and was founded in 2022. It was valued at $159 million at its early-stage round in Mar 2025, the last priced event on record. It has raised $44 million across 1 recorded round; the latest was a $34 million Series A in Mar 2025.

PMV mark · valuation
$158.5M
Oct 2026
Priced at
its early-stage round
Mar 2025
Total raised
$44.0M
Last round
Early Stage VC (Series A)
Mar 2025
What is TrueMed worth?
$158.5MPrivateMarketView mark · Oct 2026

Valued at $158.5M at its early-stage round, Mar 2025. Nothing has traded since.

Free account
More of TrueMed with a free account
  • ·Watch TrueMed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

TrueMed funding history

1 rounds
DateRoundRaisedPost-money
Mar 2025Early Stage VC (Series A)$34.0M▮
Unlock post-money valuations

Membership and data by Private Market View

TrueMed valuation

TrueMed was valued at $159 million at its early-stage round in Mar 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has TrueMed raised?

TrueMed has raised $44 million in total; 1 of its rounds is on record. The largest on record was a $34 million Series A in Mar 2025.

Comparable companies

Comparable specialty retail names by valuation on PrivateMarketView: Rugs USA ($300 million), Vaaree ($21.5 million) and HiNelson ($9.5 million).

How TrueMed's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For TrueMed, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about TrueMed

What is TrueMed worth?
TrueMed is valued at $158.5M as of Oct 2026. Valued at $158.5M at its early-stage round, Mar 2025. Nothing has traded since.
How much has TrueMed raised?
TrueMed has raised $44.0M in total funding across 1 recorded rounds.
When did TrueMed last raise?
TrueMed last raised in Mar 2025 (Early Stage VC (Series A)), raising $34.0M.